Polaryx Therapeutics, Inc.
NASDAQPLYX short interest surges 40.7% in one week to 474,004 shares as cost to borrow falls sharply to 25.4%.
Snapshot as of 20 May 2026
Polaryx Therapeutics arrives at its May 22 results having shed nearly 59% of its value over the past month — a collapse that has reset the borrowing landscape entirely, even as the ORTEX short score remains firmly…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PLYX — free to start on ORTEX.
Sign up for free →Open PLYX on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live PLYX data →